Arcadia Biosciences, Inc.: diluted weighted-average shares

What this measure means

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2021-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Reading these values

This selected numerical history matches Basic weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Selected filing history

Related financial histories

• Arcadia Biosciences, Inc.: total assets
• Arcadia Biosciences, Inc.: total liabilities
• Arcadia Biosciences, Inc.: stockholders equity
• Arcadia Biosciences, Inc.: cash and cash equivalents
• Arcadia Biosciences, Inc.: net income or loss
• Arcadia Biosciences, Inc.: operating cash flow
• Arcadia Biosciences, Inc.: capital expenditure payments
• Arcadia Biosciences, Inc.: contract revenue excluding tax
• Arcadia Biosciences, Inc.: financing cash flow
• Arcadia Biosciences, Inc.: investing cash flow
• Arcadia Biosciences, Inc.: retained earnings or deficit
• Arcadia Biosciences, Inc.: basic weighted-average shares
• Arcadia Biosciences, Inc.: basic earnings per share
• Arcadia Biosciences, Inc.: diluted earnings per share
• Arcadia Biosciences, Inc.: income tax expense or benefit
• Arcadia Biosciences, Inc.: net property, plant and equipment
• Arcadia Biosciences, Inc.: share-based compensation expense
• Arcadia Biosciences, Inc.: operating income or loss
• Arcadia Biosciences, Inc.: current assets
• Arcadia Biosciences, Inc.: interest expense
• Arcadia Biosciences, Inc.: current liabilities
• Arcadia Biosciences, Inc.: net finite-lived intangible assets
• Arcadia Biosciences, Inc.: net current accounts receivable
• Arcadia Biosciences, Inc.: operating expenses
• Arcadia Biosciences, Inc.: net inventory
• Arcadia Biosciences, Inc.: selling, general and administrative expense
• Arcadia Biosciences, Inc.: research and development expense

Inspect the source

Entity

Arcadia Biosciences, Inc. / CIK 0001469443

Captured

2026-09-20T09:07:21.204Z

SEC response SHA-256

f806f5e943ca77a8b894ab622b0441684ca24fc4c2b017f1608fffb332b90f9d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001469443.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))